Long-term evaluation of Leber’s hereditary optic neuropathy-like symptoms in rotenone administered rats

•Loss of visual function in rats after rotenone injection in the superior colliculus.•Behavioral and electrophysiological data comparable to human clinical symptoms.•Rotenone injection into rat superior colliculus serves as a model for LHON study. Leber’s hereditary optic neuropathy (LHON) is an inh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroscience letters 2015-01, Vol.585, p.171-176
Hauptverfasser: Zhang, Li, Liu, Laura, Philip, Ann L., Martinez, Juan C., Guttierez, Juan C., Marella, Mathieu, Patki, Gaurav, Matsuno-Yagi, Akemi, Yagi, Takao, Thomas, Biju B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Loss of visual function in rats after rotenone injection in the superior colliculus.•Behavioral and electrophysiological data comparable to human clinical symptoms.•Rotenone injection into rat superior colliculus serves as a model for LHON study. Leber’s hereditary optic neuropathy (LHON) is an inherited disorder affecting the retinal ganglion cells (RGCs) and their axons that lead to the loss of central vision. This study is aimed at evaluating the LHON symptoms in rats administered with rotenone microspheres into the superior colliculus (SC). Optical coherence tomography (OCT) analysis showed substantial loss of retinal nerve fiber layer (RNFL) thickness in rotenone injected rats. Optokinetic testing in rotenone treated rats showed decrease in head-tracking response. Electrophysiological mapping of the SC surface demonstrated attenuation of visually evoked responses; however, no changes were observed in the ERG data. The progressive pattern of disease manifestation in rotenone administered rats demonstrated several similarities with human disease symptoms. These rats with LHON-like symptoms can serve as a model for future investigators to design and implement reliable tests to assess the beneficial effects of therapeutic interventions for LHON disease.
ISSN:0304-3940
1872-7972
DOI:10.1016/j.neulet.2014.12.004